Paper19081488
The history and evolution of human dengue emergence.
Vasilakis N and 1 other. Adv Virus Res, 2008. Cited by 144 papers, by iCite.
Cite this record
ConductScience Library. The history and evolution of human dengue emergence. Papers, record 19081488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19081488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Historical Article, Journal Article, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Communicable Diseases, Emerging | Major topic |
| Dengue | Major topic |
| Dengue Virus | Major topic |
| Disease Outbreaks | Major topic |
| Evolution, Molecular | Major topic |
| Aedes | |
| Animals | |
| History, 20th Century | |
| Humans | |
| Insect Vectors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| T01/CCT622892 | PHS HHS | United States | PubMed |
Source PubMed
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931431 | Immunological Challenges and Emerging Strategies in Dengue Virus Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931431 | PubMed |
| 42270877 | Designing potent and immunogenic epitope based peptide vaccine against all serotypes of DENV via structural, physico-chemical and immunoinformatics-based approaches. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270877 | PubMed |
| 42132421 | Longitudinal analysis of viral and host RNA in blood and saliva during controlled human dengue virus 3 infections. | J Virol | 2026 | https://conductscience.org/library/papers/42132421 | PubMed |
| 42103722 | Host serum-circulating flavivirus NS1 co-opts mosquito miRNA processing to suppress early immune defense. | Nat Commun | 2026 | https://conductscience.org/library/papers/42103722 | PubMed |
| 41983817 | Time series analysis (2015-2022): dengue risk scenario in Goiás, Brazil. | Rev Bras Epidemiol | 2026 | https://conductscience.org/library/papers/41983817 | PubMed |
| 41501805 | Streamlining protocols for the establishment of a physical biobank of respiratory viruses in the Philippines. | J Transl Med | 2026 | https://conductscience.org/library/papers/41501805 | PubMed |
| 41009534 | The Impacts of Dengue Virus Infection on Mitochondrial Functions and Dynamics. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009534 | PubMed |
| 40866754 | Tracing Dengue's Evolutionary and Phylogenetic Pathways. | Curr Top Microbiol Immunol | 2026 | https://conductscience.org/library/papers/40866754 | PubMed |
| 40464564 | Reverse genetics rescue of sylvatic dengue viruses. | J Virol | 2025 | https://conductscience.org/library/papers/40464564 | PubMed |
| 40440170 | Future threats: Animal orthoflaviviruses that currently infect fewer than 100 people per year. | Cell Rep | 2025 | https://conductscience.org/library/papers/40440170 | PubMed |
| 40432141 | Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40432141 | PubMed |
| 40299029 | Dengue: Historical Aspects. | Curr Top Microbiol Immunol | 2026 | https://conductscience.org/library/papers/40299029 | PubMed |
| 39298440 | Vector competence of Aedes albopictus field populations from Reunion Island exposed to local epidemic dengue viruses. | PLoS One | 2024 | https://conductscience.org/library/papers/39298440 | PubMed |
| 39063563 | Unraveling the Genomic Evolution of Dengue Virus Serotype 1: A Case Study from Yantai, China. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39063563 | PubMed |
| 38655420 | Upsurge of dengue outbreaks in several WHO regions: Public awareness, vector control activities, and international collaborations are key to prevent spread. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38655420 | PubMed |
| 37334355 | Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement. | Front Immunol | 2023 | https://conductscience.org/library/papers/37334355 | PubMed |
| 37147570 | Genetic characterization of dengue virus serotype 1 circulating in Reunion Island, 2019-2021, and the Seychelles, 2015-2016. | BMC Infect Dis | 2023 | https://conductscience.org/library/papers/37147570 | PubMed |
| 36197120 | Neighboring mutation-mediated enhancement of dengue virus infectivity and spread. | EMBO Rep | 2022 | https://conductscience.org/library/papers/36197120 | PubMed |
| 35900991 | Overview of dengue outbreaks in the southwestern Indian Ocean and analysis of factors involved in the shift toward endemicity in Reunion Island: A systematic review. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35900991 | PubMed |
| 35865785 | Mysterious dengue-like virus: A case report from Pakistan. | Clin Case Rep | 2022 | https://conductscience.org/library/papers/35865785 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19081488
GET https://conductscience.org/api/papers/v1/19081488/cited_by?page=2